Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway

Blood (2021) 138 (23): 2435–2440.

https://doi.org/10.1182/blood.2021012536

Published: 2021

Includes: Supplemental data

Journal Articles

GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features

Tianjiao Wang, Andrew L. Feldman, David A. Wada, Ye Lu, Avery Polk, Robert Briski, Kay Ristow, Thomas M. Habermann, Dafydd Thomas, Steven C. Ziesmer, Linda E. Wellik, Thomas M. Lanigan, Thomas E. Witzig, Mark R. Pittelkow, Nathanael G. Bailey, Alexandra C. Hristov, Megan S. Lim, Stephen M. Ansell, Ryan A. Wilcox

Blood (2014) 123 (19): 3007–3015.

https://doi.org/10.1182/blood-2013-12-544809

Published: 2014

Includes: Supplemental data

Journal Articles

GATA-3 Expression Promotes IL-10 Production, Alternative Macrophage Polarization, and Identifies a Subset Of High-Risk PTCL, NOS

Tianjiao Wang, Ph.D., Andrew L. Feldman, David A Wada, MD, Ye Lu, MD, Avery Polk, BS, Robert Briski, BS, Kay M. Ristow, Thomas M Habermann, MD, Dafydd G Thomas, MD/Ph.D., Steven C. Ziesmer, Linda E Wellik, Thomas Lanigan, Ph.D., Thomas E Witzig, MD, Mark Pittelkow, MD, Nathanael G. Bailey, MD, Megan Lim, MD, PhD, Stephen M Ansell, M.D.Ph.D., Ryan A. Wilcox, MD, PhD

Blood (2013) 122 (21): 841.

https://doi.org/10.1182/blood.V122.21.841.841

Published: 2013

Journal Articles

Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells

Ryan A. Wilcox, David A. Wada, Steven C. Ziesmer, Sherine F. Elsawa, Nneka I. Comfere, Allan B. Dietz, Anne J. Novak, Thomas E. Witzig, Andrew L. Feldman, Mark R. Pittelkow, Stephen M. Ansell

Blood (2009) 114 (14): 2936–2944.

https://doi.org/10.1182/blood-2009-05-220111

Published: 2009

Includes: Supplemental data

Journal Articles

B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders

Ryan A. Wilcox, Andrew L. Feldman, David A. Wada, Zhi-Zhang Yang, Nneka I. Comfere, Haidong Dong, Eugene D. Kwon, Anne J. Novak, Svetomir N. Markovic, Mark R. Pittelkow, Thomas E. Witzig, Stephen M. Ansell

Blood (2009) 114 (10): 2149–2158.

https://doi.org/10.1182/blood-2009-04-216671

Published: 2009

NARROW

Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway

GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features

GATA-3 Expression Promotes IL-10 Production, Alternative Macrophage Polarization, and Identifies a Subset Of High-Risk PTCL, NOS

Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells

B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders

Email alerts

ASH Publications

American Society of Hematology

Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway

GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features

GATA-3 Expression Promotes IL-10 Production, Alternative Macrophage Polarization, and Identifies a Subset Of High-Risk PTCL, NOS

Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells

B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only